PRISMAX System for Critical Care

PRISMAX System for Critical Care

Image of PRISMAX Helios

The PRISMAX System is designed to give healthcare professionals more confidence in the delivery of continuous renal replacement therapy (CRRT), therapeutic plasma exchange (TPE) therapies and extra corporeal CO2 removal (ECCO2R).

The PRISMAX system is designed to provide individualised and effective therapies for critically ill patients on the intensive care unit (ICU). The flexible system meets the demands of multiple therapies and is compatible with a wide range of membranes for individual patient needs, including lower body weight patients.

We collaborated with critical care experts to develop the next generation of acute care technology by asking more than 650 ICU healthcare professionals from more than 50 ICUs around the world how we could help address some of their greatest challenges.

Building on 20-plus years of critical care expertise, the PRISMAX system helps clinicians improve therapy delivery through enhanced simplicity, efficiency and accuracy. The PRISMAX system builds on Baxter’s commitment to safety with integrated features that monitor therapy setup and delivery and may help reduce human error.

Simplify Therapy

The PRISMAX System is designed to simplify the complexities of delivering CRRT, which may help reduce nursing burden..

More Efficient Treatment

The PRISMAX System automates labour-intensive tasks to streamline clinician workflow.

More Accurate

The PRISMAX system’s innovative technology enables clinicians to optimise therapy by improving treatment accuracy and system performance.

Intended Use Information

The PrisMax control unit is intended for:

CRRT for patients weighing 20 kg or more with acute renal failure and/or fluid overload.

TPE therapy for patients weighing 20 kg or more with diseases where removal of plasma components is indicated.

The PrismaLung+ device is indicated to provide extracorporeal CO2 removal (ECCO2R) as a stand-alone therapy or in combination with adjunctive sepsis management therapy and/or continuous renal replacem​ent therapy (CRRT).​​ It is intended for patients weighing 30 kg or more.

All treatments administered via the PrisMax control unit must be prescribed by a physician.


WARNING! Use only fluids designed for intravenous operations and are approved for CRRT/TPE/ECCO2R usage. Do not use fluids intended for any other usage like enteral feedings/lipids or cytotoxic drugs.


For safe and proper use of products mentioned herein, please see appropriate Operators Manual or Instructions for Use.

For safe and proper use of the PRISMAX system please refer to the appropriate Instructions for Use, Operation Manual or User Guide.